These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 4759090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW.
    Munch Med Wochenschr; 1972 Jun 02; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA, Urciuoli R, Broggi G.
    Minerva Med; 1970 Jul 04; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract] [Full Text] [Related]

  • 6. An artist's view of drug-induced hallucinosis.
    Ebersbach G.
    Mov Disord; 2003 Jul 04; 18(7):833-4. PubMed ID: 12815666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB, Shealy CN, Mercier DA.
    Wis Med J; 1969 Nov 04; 68(11):325-8. PubMed ID: 4901055
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases)].
    Fasano VA, Urciuoli R, Broggi G.
    Minerva Med; 1971 Oct 31; 62(82):3968-70. PubMed ID: 5125055
    [No Abstract] [Full Text] [Related]

  • 11. [Amantadine for parkinsonism].
    Flatberg P.
    Tidsskr Nor Laegeforen; 1970 May 15; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D, Friedman A.
    Mov Disord; 2007 May 15; 22(7):1033-6. PubMed ID: 17370308
    [Abstract] [Full Text] [Related]

  • 15. [Clinical results of the intravenous administration of amantadine in patients with parkinsonism].
    Caliri F, Di Rosa AE, Meduri M, Megna G, Musolino R, Scuderi D.
    Minerva Med; 1971 Oct 31; 62(82):3994-6. PubMed ID: 5125062
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP, Braga-Neto P, Sueli Monte F, de Bruin VM.
    Parkinsonism Relat Disord; 2005 Nov 31; 11(7):449-52. PubMed ID: 16154788
    [Abstract] [Full Text] [Related]

  • 20. [Amantadine in the treatment of Parkinson's disease].
    Giombini S, Solero CL, Bazzan A, Ferrari P, Robotti E.
    Fracastoro; 1970 Nov 31; 63(6):869-81. PubMed ID: 5519639
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.